The latest price target for Chemed (NYSE:CHE) was reported by RBC Capital on February 27, 2026. The analyst firm set a price target for $422.00 expecting CHE to rise to within 12 months (a possible 10.22% upside). 12 analyst firms have reported ratings in the last year.

The latest analyst rating for Chemed (NYSE:CHE) was provided by RBC Capital, and Chemed downgraded their sector perform rating.

The last upgrade for Chemed Corp happened on September 2, 2025 when Jefferies raised their price target to $550. Jefferies previously had a hold for Chemed Corp.

The last downgrade for Chemed Corp happened on February 27, 2026 when RBC Capital changed their price target from $572 to $422 for Chemed Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chemed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chemed was filed on February 27, 2026 so you should expect the next rating to be made available sometime around February 27, 2027.

While ratings are subjective and will change, the latest Chemed (CHE) rating was a downgraded with a price target of $572.00 to $422.00. The current price Chemed (CHE) is trading at is $382.88, which is out of the analyst’s predicted range.